| Scrip Code | 540701 |
|---|---|
| NSE Symbol | DCAL |
| MSEI Symbol | NA |
| ISIN | INE385W01011 |
| Name of company | Dishman Carbogen Amcis Limited |
| Type of company | Main Board |
| Class of security | Equity |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 04-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 30-10-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Consolidated |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Segment Reporting | Single segment |
| Description of single segment | Contract Development and Manufacturing Organisation (CDMO), quats, specialty chemicals, Vitamins D3 and its analogues, cholesterols, disinfectants etc. |
| Start date and time of board meeting | 04-11-2025 14:00:00 |
| End date and time of board meeting | 04-11-2025 20:00:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Indirect |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| 1 | Income | ||
| Revenue from operations | 65,265.00 | 1,36,070.00 | |
| Other income | 811.00 | 3,286.00 | |
| Total income | 66,076.00 | 1,39,356.00 | |
| 2 | Expenses | ||
| (a) | Cost of materials consumed | 3,410.00 | 23,970.00 |
| (b) | Purchases of stock-in-trade | 0.00 | 0.00 |
| (c) | Changes in inventories of finished goods, work-in-progress and stock-in-trade | 21.00 | (10,730.00) |
| (d) | Employee benefit expense | 33,294.00 | 68,484.00 |
| (e) | Finance costs | 4,233.00 | 8,509.00 |
| (f) | Depreciation, depletion and amortisation expense | 8,413.00 | 16,548.00 |
| (f) | Other Expenses | ||
| 1 | Other Expenditure | 13,651.00 | 25,389.00 |
| Total other expenses | 13,651.00 | 25,389.00 | |
| Total expenses | 63,022.00 | 1,32,170.00 | |
| 3 | Total profit before exceptional items and tax | 3,054.00 | 7,186.00 |
| 4 | Exceptional items | 0.00 | (265.00) |
| 5 | Total profit before tax | 3,054.00 | 6,921.00 |
| 6 | Tax expense | ||
| 7 | Current tax | 346.00 | 2,209.00 |
| 8 | Deferred tax | (3,819.00) | (4,156.00) |
| 9 | Total tax expenses | (3,473.00) | (1,947.00) |
| 10 | Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement | 0.00 | 0.00 |
| 11 | Net Profit Loss for the period from continuing operations | 6,527.00 | 8,868.00 |
| 12 | Profit (loss) from discontinued operations before tax | 0.00 | 0.00 |
| 13 | Tax expense of discontinued operations | 0.00 | 0.00 |
| 14 | Net profit (loss) from discontinued operation after tax | 0.00 | 0.00 |
| 15 | Share of profit (loss) of associates and joint ventures accounted for using equity method | 0.00 | 0.00 |
| 16 | Total profit (loss) for period | 6,527.00 | 8,868.00 |
| 17 | Other comprehensive income net of taxes | 11,617.00 | 44,476.00 |
| 18 | Total Comprehensive Income for the period | 18,144.00 | 53,344.00 |
| 19 | Total profit or loss, attributable to | ||
| Profit or loss, attributable to owners of parent | 6,527.00 | 8,868.00 | |
| Total profit or loss, attributable to non-controlling interests | 0.00 | 0.00 | |
| 20 | Total Comprehensive income for the period attributable to | ||
| Comprehensive income for the period attributable to owners of parent | 11,617.00 | 44,476.00 | |
| Total comprehensive income for the period attributable to owners of parent non-controlling interests | 18,144.00 | 53,344.00 | |
| 21 | Details of equity share capital | ||
| Paid-up equity share capital | 3,136.00 | 3,136.00 | |
| Face value of equity share capital | 2 | 2 | |
| 27 | Details of debt securities | ||
| 22 | Reserves excluding revaluation reserve | ||
| 23 | Earnings per share | ||
| i | Earnings per equity share for continuing operations | ||
| Basic earnings (loss) per share from continuing operations | 4.16 | 5.66 | |
| Diluted earnings (loss) per share from continuing operations | 4.16 | 5.66 | |
| ii | Earnings per equity share for discontinued operations | ||
| Basic earnings (loss) per share from discontinued operations | 0 | 0 | |
| Diluted earnings (loss) per share from discontinued operations | 0 | 0 | |
| ii | Earnings per equity share | ||
| Basic earnings (loss) per share from continuing and discontinued operations | 4.16 | 5.66 | |
| Diluted earnings (loss) per share from continuing and discontinued operations | 4.16 | 5.66 | |
| 24 | Debt equity ratio | 0.3500 | 0.3500 |
| 25 | Debt service coverage ratio | 1.4900 | 1.4900 |
| 26 | Interest service coverage ratio | 3.3200 | 3.3200 |
| 27 | Disclosure of notes on financial results | Textual Information(1) | |
| Textual Information(1) | Note for full notes to FR pls refer Outcome of Board Meeting |
|---|
| Debt equity ratio | |
|---|---|
| Debt service coverage ratio | |
| Interest service coverage ratio |
| Particulars | Year ended (dd-mm-yyyy) | |
|---|---|---|
| Date of start of reporting period | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | |
| Nature of report standalone or consolidated | Consolidated | |
| Assets | ||
| 1 | Non-current assets | |
| Property, plant and equipment | 2,83,787.00 | |
| Capital work-in-progress | 30,868.00 | |
| Investment property | 450.00 | |
| Goodwill | 4,54,783.00 | |
| Other intangible assets | 31,863.00 | |
| Intangible assets under development | 24,467.00 | |
| Biological assets other than bearer plants | 0.00 | |
| Investments accounted for using equity method | 0.00 | |
| Non-current financial assets | ||
| Non-current investments | 7,515.00 | |
| Trade receivables, non-current | 0.00 | |
| Loans, non-current | 178.00 | |
| Other non-current financial assets | 3,378.00 | |
| Total non-current financial assets | 11,071.00 | |
| Deferred tax assets (net) | 8,080.00 | |
| Other non-current assets | 21,287.00 | |
| Total non-current assets | 8,66,656.00 | |
| 2 | Current assets | |
| Inventories | 1,02,767.00 | |
| Current financial asset | ||
| Current investments | 1,573.00 | |
| Trade receivables, current | 65,525.00 | |
| Cash and cash equivalents | 46,380.00 | |
| Bank balance other than cash and cash equivalents | 15,191.00 | |
| Loans, current | 391.00 | |
| Other current financial assets | 621.00 | |
| Total current financial assets | 1,29,681.00 | |
| Current tax assets (net) | 0.00 | |
| Other current assets | 11,810.00 | |
| Total current assets | 2,44,258.00 | |
| 3 | Non-current assets classified as held for sale | 0.00 |
| 4 | Regulatory deferral account debit balances and related deferred tax Assets | 0.00 |
| Total assets | 11,10,914.00 | |
| Equity and liabilities | ||
| 1 | Equity | |
| Equity attributable to owners of parent | ||
| Equity share capital | 3,136.00 | |
| Other equity | 6,33,360.00 | |
| Total equity attributable to owners of parent | 6,36,496.00 | |
| Non controlling interest | 0.00 | |
| Total equity | 6,36,496.00 | |
| 2 | Liabilities | |
| Non-current liabilities | ||
| Non-current financial liabilities | ||
| Borrowings, non-current | 1,16,557.00 | |
| Trade payables, non-current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 0.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 0.00 | |
| Total Trade payable | 0.00 | |
| Other non-current financial liabilities | 25,985.00 | |
| Total non-current financial liabilities | 1,42,542.00 | |
| Provisions, non-current | 40,469.00 | |
| Deferred tax liabilities (net) | 1,314.00 | |
| Deferred government grants, Non-current | 0.00 | |
| Other non-current liabilities | 68,342.00 | |
| Total non-current liabilities | 2,52,667.00 | |
| Current liabilities | ||
| Current financial liabilities | ||
| Borrowings, current | 1,07,870.00 | |
| Trade payables, current | ||
| (A) Total outstanding dues of micro enterprises and small enterprises | 684.00 | |
| (B) Total outstanding dues of creditors other than micro enterprises and small enterprises | 18,896.00 | |
| Total Trade payable | 19,580.00 | |
| Other current financial liabilities | 44,681.00 | |
| Total current financial liabilities | 1,72,131.00 | |
| Other current liabilities | 42,631.00 | |
| Provisions, current | 1,656.00 | |
| Current tax liabilities (Net) | 5,333.00 | |
| Deferred government grants, Current | 0.00 | |
| Total current liabilities | 2,21,751.00 | |
| 3 | Liabilities directly associated with assets in disposal group classified as held for sale | 0.00 |
| 4 | Regulatory deferral account credit balances and related deferred tax liability | 0.00 |
| Total liabilities | 4,74,418.00 | |
| Total equity and liabilites | 11,10,914.00 | |
| Disclosure of notes on assets and liabilities | ||
| Particulars | 3 months/ 6 month ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|---|
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |||||
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |||||
| Whether results are audited or unaudited | Unaudited | Unaudited | |||||
| Nature of report standalone or consolidated | Consolidated | Consolidated | |||||
| 1 | Segment Revenue (Income) | ||||||
| (net sale/income from each segment should be disclosed) | |||||||
| Total Segment Revenue | |||||||
| Less: Inter segment revenue | |||||||
| Revenue from operations | |||||||
| 2 | Segment Result | ||||||
| Profit (+) / Loss (-) before tax and interest from each segment | |||||||
| Total Profit before tax | |||||||
| i. Finance cost | |||||||
| ii. Other Unallocable Expenditure net off Unallocable income | |||||||
| Profit before tax | |||||||
| 3 | (Segment Asset - Segment Liabilities) | ||||||
| Segment Asset | |||||||
| Total Segment Asset | |||||||
| Un-allocable Assets | null | null | |||||
| Net Segment Asset | null | null | |||||
| 4 | Segment Liabilities | ||||||
| Segment Liabilities | |||||||
| Total Segment Liabilities | |||||||
| Un-allocable Liabilities | null | null | |||||
| Net Segment Liabilities | null | null | |||||
| Disclosure of notes on segments | |||||||
| Particulars | 3 months/ 6 months ended (dd-mm-yyyy) | Year to date figures for current period ended (dd-mm-yyyy) | |
|---|---|---|---|
| A | Date of start of reporting period | 01-07-2025 | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Consolidated | Consolidated |
| Other comprehensive income [Abstract] | |||
| 1 | Amount of items that will not be reclassified to profit and loss | ||
| 1 | Remeasurement gain/(losses) on defined benefit plans | 783.00 | 803.00 |
| 2 | Changes in fair value of FVTOCI equity instruments | 1.00 | 1.00 |
| Total Amount of items that will not be reclassified to profit and loss | 784.00 | 804.00 | |
| 2 | Income tax relating to items that will not be reclassified to profit or loss | 77.00 | 84.00 |
| 3 | Amount of items that will be reclassified to profit and loss | ||
| 1 | Movement in foreign currency translation reserve | 12,221.00 | 50,537.00 |
| 2 | Foreign exchange fluctuations in respect of cash flow hedge | (2,319.00) | (9,420.00) |
| Total Amount of items that will be reclassified to profit and loss | 9,902.00 | 41,117.00 | |
| 4 | Income tax relating to items that will be reclassified to profit or loss | (1,008.00) | (2,639.00) |
| 5 | Total Other comprehensive income | 11,617.00 | 44,476.00 |
| Particulars | Year ended (dd-mm-yyyy) | |||||
|---|---|---|---|---|---|---|
| A | Date of start of reporting period | 01-04-2025 | ||||
| B | Date of end of reporting period | 30-09-2025 | ||||
| C | Whether results are audited or unaudited | Unaudited | ||||
| D | Nature of report standalone or consolidated | Consolidated | ||||
| Statement of cash flows | ||||||
| Cash flows from used in operating activities | ||||||
| Profit before tax | 6,921.00 | |||||
| Adjustments for reconcile profit (loss) | ||||||
| Adjustments for finance costs | 0.00 | |||||
| Adjustments for decrease (increase) in inventories | (13,009.00) | |||||
| Adjustments for decrease (increase) in trade receivables, current | 3,519.00 | |||||
| Adjustments for decrease (increase) in trade receivables, non-current | 0.00 | |||||
| Adjustments for decrease (increase) in other current assets | (4,320.00) | |||||
| Adjustments for decrease (increase) in other non-current assets | 0.00 | |||||
| Adjustments for other financial assets, non-current | 0.00 | |||||
| Adjustments for other financial assets, current | 0.00 | |||||
| Adjustments for other bank balances | 0.00 | |||||
| Adjustments for increase (decrease) in trade payables, current | 22,977.00 | |||||
| Adjustments for increase (decrease) in trade payables, non-current | 0.00 | |||||
| Adjustments for increase (decrease) in other current liabilities | 0.00 | |||||
| Adjustments for increase (decrease) in other non-current liabilities | 0.00 | |||||
| Adjustments for depreciation and amortisation expense | 16,548.00 | |||||
| Adjustments for impairment loss reversal of impairment loss recognised in profit or loss | 0.00 | |||||
| Adjustments for provisions, current | 0.00 | |||||
| Adjustments for provisions, non-current | 0.00 | |||||
| Adjustments for other financial liabilities, current | 0.00 | |||||
| Adjustments for other financial liabilities, non-current | 0.00 | |||||
| Adjustments for unrealised foreign exchange losses gains | (6,996.00) | |||||
| Adjustments for dividend income | 0.00 | |||||
| Adjustments for interest income | 72.00 | |||||
| Adjustments for share-based payments | 0.00 | |||||
| Adjustments for fair value losses (gains) | 0.00 | |||||
| Adjustments for undistributed profits of associates | 0.00 | |||||
| Other adjustments for which cash effects are investing or financing cash flow | 0.00 | |||||
| Other adjustments to reconcile profit (loss) | 0.00 | |||||
| Other adjustments for non-cash items | (4,181.00) | |||||
| Share of profit and loss from partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Total adjustments for reconcile profit (loss) | 14,466.00 | |||||
| Net cash flows from (used in) operations | 21,387.00 | |||||
| Dividends received | 0.00 | |||||
| Interest paid | (8,509.00) | |||||
| Interest received | 0.00 | |||||
| Income taxes paid (refund) | 373.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) operating activities | 29,523.00 | |||||
| Cash flows from used in investing activities | ||||||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |||||
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |||||
| Other cash receipts from sales of equity or debt instruments of other entities | 0.00 | |||||
| Other cash payments to acquire equity or debt instruments of other entities | 0.00 | |||||
| Other cash receipts from sales of interests in joint ventures | 0.00 | |||||
| Other cash payments to acquire interests in joint ventures | 0.00 | |||||
| Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Cash payment for investment in partnership firm or association of persons or limited liability partnerships | 0.00 | |||||
| Proceeds from sales of property, plant and equipment | 3.00 | |||||
| Purchase of property, plant and equipment | 11,838.00 | |||||
| Proceeds from sales of investment property | 0.00 | |||||
| Purchase of investment property | 0.00 | |||||
| Proceeds from sales of intangible assets | 0.00 | |||||
| Purchase of intangible assets | 0.00 | |||||
| Proceeds from sales of intangible assets under development | 0.00 | |||||
| Purchase of intangible assets under development | 0.00 | |||||
| Proceeds from sales of goodwill | 0.00 | |||||
| Purchase of goodwill | 0.00 | |||||
| Proceeds from biological assets other than bearer plants | 0.00 | |||||
| Purchase of biological assets other than bearer plants | 0.00 | |||||
| Proceeds from government grants | 0.00 | |||||
| Proceeds from sales of other long-term assets | 0.00 | |||||
| Purchase of other long-term assets | 0.00 | |||||
| Cash advances and loans made to other parties | 0.00 | |||||
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |||||
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |||||
| Dividends received | 0.00 | |||||
| Interest received | 97.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 2,795.00 | |||||
| Net cash flows from (used in) investing activities | (8,943.00) | |||||
| Cash flows from used in financing activities | ||||||
| Proceeds from changes in ownership interests in subsidiaries | 0.00 | |||||
| Payments from changes in ownership interests in subsidiaries | 0.00 | |||||
| Proceeds from issuing shares | 0.00 | |||||
| Proceeds from issuing other equity instruments | 0.00 | |||||
| Payments to acquire or redeem entity's shares | 0.00 | |||||
| Payments of other equity instruments | 0.00 | |||||
| Proceeds from exercise of stock options | 0.00 | |||||
| Proceeds from issuing debentures notes bonds etc | 0.00 | |||||
| Proceeds from borrowings | 21,361.00 | |||||
| Repayments of borrowings | 18,562.00 | |||||
| Payments of lease liabilities | 3,094.00 | |||||
| Dividends paid | 0.00 | |||||
| Interest paid | 8,012.00 | |||||
| Income taxes paid (refund) | 0.00 | |||||
| Other inflows (outflows) of cash | 0.00 | |||||
| Net cash flows from (used in) financing activities | (8,307.00) | |||||
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 12,273.00 | |||||
| Effect of exchange rate changes on cash and cash equivalents | ||||||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |||||
| Net increase (decrease) in cash and cash equivalents | 12,273.00 | |||||
| Cash and cash equivalents cash flow statement at beginning of period | 34,107.00 | |||||
| Cash and cash equivalents cash flow statement at end of period | 46,380.00 | |||||